NCT05350163
T-cell Receptor α/β Depleted Donor Lymphocyte Infusion No drug interventions treatment 1 active_not_recruiting NCT01111396
Longitudinal Investigation of Hippocampal Function and Morphology in Acute Lymphatic Leukemia (ALL) Patients Treated With Chemotherapy No drug interventions Not Available Not Available unknown_status NCT06508775
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies other Not Available recruiting NCT05250869
Comparative Quantification of MTX and Its Metabolites Post Glucarpidase No drug interventions Not Available Not Available completed NCT00313053
Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia treatment 1 terminated NCT03615105
Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors treatment 2 terminated NCT04872595
A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant treatment 2 active_not_recruiting NCT00185523
Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) No drug interventions Not Available Not Available terminated NCT01768845
Unrelated Umbilical Cord Blood (UBC)Transplantation No drug interventions treatment Not Available completed NCT02071927
Study of the Glutaminase Inhibitor CB-839 in Leukemia treatment 1 completed NCT03592576
Expanded Access to Navitoclax Not Available Not Available no_longer_available NCT00664677
Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia treatment 1 terminated NCT01962636
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases treatment Not Available recruiting NCT00566696
Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies treatment 2 completed NCT02086773
Red Cell Transfusion Goals in Patients With Acute Leukemias No drug interventions supportive_care 1 completed NCT03291444
CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS No drug interventions treatment 1 recruiting NCT00923910
Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood treatment 1 / 2 completed NCT00186823
Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies No drug interventions treatment 3 completed NCT00088543
Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant Not Available Not Available completed NCT03448393
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies treatment 1 recruiting NCT05442515
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies treatment 1 / 2 recruiting NCT05923112
BESPONSA Injection 1 mg Special Investigation No drug interventions Not Available Not Available completed NCT04988555
A Study of DSP-5336 in Relapsed/refractory AML/ ALL with or Without MLL Rearrangement or NPM1 Mutation treatment 1 / 2 recruiting NCT06131801
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution No drug interventions Not Available Not Available active_not_recruiting NCT06476665
A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia. No drug interventions Not Available Not Available not_yet_recruiting NCT01430390
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies treatment 1 active_not_recruiting NCT03544021
CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL） treatment 1 / 2 unknown_status NCT01338987
Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation treatment 2 completed NCT02043587
Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma treatment 2 terminated NCT00990587
Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy treatment 1 completed NCT03110354
DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL) No drug interventions treatment 1 terminated NCT00352677
Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia treatment 1 completed NCT05456698
Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction Chemotherapy treatment 2 not_yet_recruiting NCT05292898
A Triple-targeted Cell Preparation Targeting CD19/CD20/CD22 in Patients With Relapsed/Refractory B-cell Acute Lymphocytic Leukemia No drug interventions treatment 1 active_not_recruiting NCT05805605
Allo HSCT Using RIC and PTCy for Hematological Diseases treatment 2 recruiting NCT02765997
StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies No drug interventions treatment 2 withdrawn NCT00038883
Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies treatment Not Available terminated NCT05727683
CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia treatment 1 recruiting NCT01500161
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match treatment 2 terminated NCT02141828
A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene treatment 1 completed NCT01965171
Transfusional Iron Overload Among Leukemia Survivors No drug interventions Not Available Not Available completed NCT01597778
Double Cord Versus Haploidentical (BMT CTN 1101) No drug interventions treatment 3 completed NCT00852709
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias treatment 1 terminated NCT01037556
PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia No drug interventions treatment 1 / 2 unknown_status NCT01078337
T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis No drug interventions Not Available Not Available completed NCT03696537
IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT treatment 1 terminated NCT03076437
Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies No drug interventions treatment 1 / 2 completed NCT02670252
BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT treatment 3 completed NCT05021159
Assessing the Ontogeny of P-glycoprotein Expression in Blood of Pediatric Leukemic Patients No drug interventions Not Available Not Available completed NCT04796675
Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies treatment 1 unknown_status NCT00975975
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer treatment 2 completed NCT00309842
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases treatment 2 completed NCT05775406
Safety and Clinical Activity of KT-253 in Adult Patients With High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors treatment 1 recruiting NCT00149136
Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy. Not Available 2 unknown_status NCT01745913
Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies treatment 2 terminated NCT01272817
Nonmyeloablative Allogeneic Transplant No drug interventions treatment Not Available completed NCT00907517
Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247) treatment 1 terminated NCT01634217
Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation No drug interventions treatment 1 completed NCT00905034
Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage treatment 2 completed NCT05326516
A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia treatment 1 completed NCT00349596
A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL) treatment 1 completed NCT01491958
Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation supportive_care 2 completed NCT02661035
Allo HSCT Using RIC for Hematological Diseases treatment 2 completed NCT00763763
Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive treatment 2 completed NCT00271063
Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia treatment 1 / 2 unknown_status NCT01890486
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen No drug interventions Not Available Not Available recruiting NCT05044039
Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy treatment 1 recruiting NCT03056339
Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies treatment 1 / 2 completed NCT00176839
Stem Cell Transplantation for Hematological Malignancies treatment 2 / 3 terminated NCT00176930
Stem Cell Transplant for Hematological Malignancy treatment Not Available terminated NCT04629430
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT No drug interventions treatment Not Available completed NCT00145626
HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies treatment 2 completed NCT03066466
Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT prevention 3 withdrawn NCT01167166
Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL) treatment 1 / 2 completed NCT05154474
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy No drug interventions Not Available Not Available unknown_status NCT01853631
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN) No drug interventions treatment 1 recruiting NCT00548431
NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic Leukemia treatment 2 completed NCT01162031
Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia treatment 2 withdrawn NCT03191773
A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies No drug interventions treatment 1 / 2 unknown_status NCT00586391
CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL treatment 1 active_not_recruiting NCT01572662
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning treatment 2 completed NCT00176462
CINJALL: Treatment for Children With Acute Lymphocytic Leukemia treatment 2 completed NCT00393380
Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor prevention 2 terminated NCT00001689
A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia treatment 1 completed NCT02851589
Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma No drug interventions treatment 1 / 2 unknown_status NCT00701844
Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors No drug interventions treatment Not Available completed NCT00155844
Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier" No drug interventions Not Available Not Available unknown_status NCT00167167
Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia No drug interventions treatment Not Available completed NCT01163201
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies treatment 1 / 2 withdrawn NCT04771572
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. No drug interventions treatment 1 recruiting NCT04940468
High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology No drug interventions prevention Not Available recruiting NCT00251368
Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia treatment 1 completed NCT01310946
Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology No drug interventions Not Available Not Available unknown_status NCT02315612
Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies No drug interventions treatment 1 active_not_recruiting NCT05811910
Genetic Polymorphisms in Drug Induced Neuropathy in Children With ALL No drug interventions Not Available Not Available recruiting NCT00061581
Experimental Bone Marrow Transplant Protocol No drug interventions treatment 2 completed NCT00963495
Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy treatment 1 terminated NCT03755414
Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation treatment 1 completed NCT01586455
Human Placental-Derived Stem Cell Transplantation No drug interventions treatment 1 completed NCT04803123
Window Trial to Evaluate Molecular Response to PI3K Inhibition With Copanlisib in r/r Adult B-cell ALL treatment 0 terminated NCT00594308
In-Vivo Activated T-Cell Depletion to Prevent GVHD treatment Not Available terminated NCT01551043
Allo CART-19 Protocol treatment 1 terminated NCT00067002
Randomized Double Cord Blood Transplant Study treatment 2 completed NCT00697684
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant treatment 1 completed NCT00526084
Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan No drug interventions Not Available Not Available unknown_status NCT00674479
INCB018424 in Patients With Advanced Hematologic Malignancies treatment 2 completed NCT00313079
Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia treatment 1 completed NCT02374333
Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy No drug interventions treatment 1 completed NCT00098033
Investigation of Clofarabine in Acute Leukemias treatment 2 completed NCT02750254
Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation treatment 1 terminated NCT00968253
RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia treatment 1 / 2 completed NCT02914977
Low-Dose Daunorubicin in Relapsed/Refractory Acute Leukemia treatment 1 completed NCT01350245
Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor treatment 2 completed NCT05565105
CD34+ Transplants for Leukemia and Lymphoma treatment 2 not_yet_recruiting NCT01363297
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia treatment 2 completed NCT05201183
A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed and Refractory Hematologic Malignancies treatment 1 / 2 withdrawn NCT02819583
CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma No drug interventions treatment 1 / 2 unknown_status NCT00467961
Stem Cell Transplantation for Patients With Cancers of the Blood No drug interventions treatment 2 completed NCT05170828
Cryopreserved MMUD BM With PTCy for Hematologic Malignancies treatment 1 withdrawn NCT03674411
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy treatment 2 active_not_recruiting NCT00406393
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) treatment 3 completed NCT02581007
Reduced Intensity Conditioning Transplant Using Haploidentical Donors treatment 2 completed NCT03088709
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide prevention 2 terminated NCT03263637
Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies treatment 1 completed NCT04004637
CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia No drug interventions treatment 1 unknown_status NCT00483132
Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III treatment 3 completed NCT00516152
Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT treatment 2 completed NCT02410252
Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies No drug interventions other Not Available completed NCT00773149
Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic Leukemia treatment 1 / 2 completed NCT01049113
Safety Study of ON 013105 in Lymphoma and Acute Lymphoid Leukemia treatment 1 terminated NCT05410041
Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory B-cell Malignancies No drug interventions treatment 1 unknown_status NCT03840317
Senl_1904A and Senl_1904B Chimeric Antigen Receptor （CAR） T-Cell in the Treatment of r/ r Acute B Lymphocytic Leukemia No drug interventions treatment 1 unknown_status NCT00089596
Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers No drug interventions treatment 1 / 2 completed NCT01100658
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors treatment Not Available terminated NCT06481735
TCR Reserved and Power3 Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL treatment 1 / 2 recruiting NCT02007863
Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia treatment Not Available completed NCT01075425
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome treatment 1 completed NCT00304720
Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor treatment 2 unknown_status NCT02129582
Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies treatment 1 completed NCT00412360
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) treatment 3 completed NCT03104491
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia treatment 1 / 2 recruiting NCT01930162
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant basic_science 2 completed NCT00246662
Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies treatment 1 completed NCT00571662
Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant treatment 2 completed NCT00167180
Post Transplant Donor Lymphocyte Infusion treatment 2 terminated NCT00005892
Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia treatment Not Available completed NCT03934372
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors treatment 1 / 2 recruiting NCT00854646
Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS) treatment 1 completed NCT01050946
Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit No drug interventions treatment 2 terminated NCT01474681
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies treatment 1 / 2 completed NCT01600781
Effect of Oral Supplementation With a Fibre Enriched Paediatric Sip Feed For Children With Acute Lymphocytic Leukemia No drug interventions supportive_care Not Available completed NCT02892695
PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma treatment 1 / 2 unknown_status NCT01702155
Phase I/II Study of DFP-10917 in Patients With Acute Leukemia No drug interventions treatment 1 / 2 completed NCT03633955
Pilot Imaging Study of Leukemia No drug interventions diagnostic 1 recruiting NCT03555955
A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 treatment 1 completed NCT00537550
Adult ALL Treatment at Diagnosis treatment Not Available completed NCT02456350
Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies treatment 1 unknown_status NCT02593123
Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis treatment 2 completed NCT00430443
Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML treatment 1 terminated NCT00475384
Haploidentical Transplantation in Patients With Acute Leukemia and Myelodysplasia treatment 1 completed NCT05086315
First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) No drug interventions treatment 1 / 2 recruiting NCT01440179
SAR3419 in Acute Lymphoblastic Leukemia treatment 2 terminated NCT03760237
Cardiovascular Function in Acute Leukemia No drug interventions Not Available Not Available completed NCT05322850
Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT) No drug interventions treatment 1 / 2 suspended NCT05535855
UCD19 CAR T Therapy in Adults with B-ALL and MRD Positivity in CR1 No drug interventions treatment 1 recruiting NCT05827549
Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia health_services_research 2 recruiting NCT03977103
Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT No drug interventions treatment 2 unknown_status NCT01720264
Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant treatment 2 completed NCT01037764
Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL) No drug interventions treatment 2 terminated NCT02413021
The Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy Regimens treatment 1 unknown_status NCT04778579
Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy treatment 2 active_not_recruiting NCT04167683
Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant No drug interventions Not Available Not Available recruiting NCT01749111
Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis prevention 3 terminated NCT02767388
Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery No drug interventions Not Available Not Available completed NCT02294552
Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT treatment 2 completed NCT05166135
Latin American Real-world Study in Acute Leukemia No drug interventions Not Available Not Available completed NCT02458235
Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation treatment 2 completed NCT02953730
The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents No drug interventions treatment 4 completed NCT06427330
Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia prevention 2 recruiting NCT05587088
Evaluation of the Safety and Efficacy of Esperanza Extract (PA001) No drug interventions treatment 1 / 2 not_yet_recruiting NCT05959720
Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil Not Available Not Available recruiting NCT01344876
Phase I Study of OPB-51602 in Patients With Hematologic Malignancies No drug interventions treatment 1 completed NCT02605460
Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission treatment 2 unknown_status NCT03833180
A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001) treatment 1 completed NCT05316701
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies No drug interventions treatment 3 active_not_recruiting NCT04669210
PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT prevention 2 active_not_recruiting NCT02435550
iCare for Cancer Patients No drug interventions diagnostic Not Available terminated NCT00983138
Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL) treatment 2 completed NCT06551584
Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT treatment 1 not_yet_recruiting NCT02933333
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor treatment 4 unknown_status NCT03792633
Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL No drug interventions treatment 2 active_not_recruiting NCT05150561
Muscle Dysfunction in Patients With Haematological Diseases No drug interventions Not Available Not Available unknown_status NCT05943093
H19 in Acute Lymphoblastic Leukemia. No drug interventions Not Available Not Available not_yet_recruiting NCT05792007
Study of the Medullary Microenvironment in Acute Childhood Leukemia No drug interventions diagnostic Not Available recruiting NCT04013685
Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies No drug interventions treatment 1 active_not_recruiting NCT02345915
Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute Leukemia No drug interventions basic_science Not Available unknown_status NCT00590915
Erwinase Master Treatment Protocol Not Available Not Available no_longer_available NCT03367299
Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia treatment 2 unknown_status NCT02523976
Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia treatment 2 completed NCT04464889
HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation No drug interventions treatment 1 withdrawn NCT02419755
Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies treatment 2 terminated NCT01461538
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies treatment 2 completed NCT03610438
Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia treatment 2 unknown_status